<DOC>
	<DOCNO>NCT00918021</DOCNO>
	<brief_summary>The aim randomize , double-blind study verify hypothesis clozapine monotherapy efficient combination clozapine olanzapine therapy treatment-resistant schizophrenia . A third schizophrenia patient non -responders medication use nowadays . These patient usually treat clozapine , large proportion patient n't recover sufficiently . Therefore , patient treat combination two drug achieve good treatment result . Until scientific evidence insufficient assess utility polypharmacy . The aim study 2009 voluntary patient , benefit olanzapine augmentation compare pure clozapine monotherapy . During study patient expose additional intervention . The intervention study reduce previously use polypharmacy . Methods : This study last 24 week . Participants ( 30 ) randomize one two alternative intervention ( A B ) study . After 12 week intervention arm cross ( A B B A ) . Group B : In addition clozapine , participant receive normal dosage olanzapine ( =the hospital ward ) 12 week , next decreasing dosage olanzapine four week subsequently placebo 8 week Group A : : In addition clozapine participant receive decrease dosage olanzapine four week , next placebo 8 week , increase dosage olanzapine four week subsequently normal dosage olanzapine 8 week The response medical treatment assess Clinical Global Improvement Scale ( CGIS ) Global Assessment Functioning ( GAF ) -scale . The primary outcome GAF modify CGIS parallel phase study ( first 12 week ) . The second phase ( last 12 week ) cross-over study use secondary analysis . The use additional medication ( benzodiazepine ) use secondary outcome measure .</brief_summary>
	<brief_title>Polypharmacy Clozapine-resistant Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Clozapine</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>age â‰¥18 year , ( adult ) , legally competent patient able understand purpose study eligible sign write informed consent form . insufficient response valid clozapineolanzapine polypharmacy psychotropic medication constant ( unchangeable ) past 2 month Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
</DOC>